{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:09:38Z","timestamp":1790770178393,"version":"4.1.0"},"reference-count":54,"publisher":"Impact Journals, LLC","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,5,23]]},"DOI":"10.18632\/oncotarget.16602","type":"journal-article","created":{"date-parts":[[2017,3,27]],"date-time":"2017-03-27T19:56:17Z","timestamp":1490644577000},"page":"34552-34564","source":"Crossref","is-referenced-by-count":15,"title":["Targeting mantle cell lymphoma metabolism and survival through simultaneous blockade of mTOR and nuclear transporter exportin-1"],"prefix":"10.18632","volume":"8","author":[{"given":"Kazumasa","family":"Sekihara","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan"},{"name":"Leading Center for the Development and Research of Cancer Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Saitoh","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Han","sequence":"additional","affiliation":[{"name":"Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Ciurea","sequence":"additional","affiliation":[{"name":"Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan"},{"name":"Leading Center for the Development and Research of Cancer Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Kikkawa","sequence":"additional","affiliation":[{"name":"Laboratory of Proteomics and Biomolecular Science, Research Support Center, Juntendo University Graduate School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saiko","family":"Kazuno","sequence":"additional","affiliation":[{"name":"Laboratory of Proteomics and Biomolecular Science, Research Support Center, Juntendo University Graduate School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikari","family":"Taka","sequence":"additional","affiliation":[{"name":"Laboratory of Proteomics and Biomolecular Science, Research Support Center, Juntendo University Graduate School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Kaga","sequence":"additional","affiliation":[{"name":"Laboratory of Proteomics and Biomolecular Science, Research Support Center, Juntendo University Graduate School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Arai","sequence":"additional","affiliation":[{"name":"Laboratory of Proteomics and Biomolecular Science, Research Support Center, Juntendo University Graduate School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Miida","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Andreeff","sequence":"additional","affiliation":[{"name":"Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Konopleva","sequence":"additional","affiliation":[{"name":"Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Tabe","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan"},{"name":"Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA"},{"name":"Department of Next Genertion Hematology Laboratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,3,27]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/annonc\/mdn045","article-title":"Intensive treatment strategies may not provide superior outcomes in mantle cell lymphoma: overall survival exceeding 7 years with standard therapies","volume":"19","author":"Schuster","year":"2008","journal-title":"Ann Oncol"},{"key":"2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1182\/blood-2010-04-189977","article-title":"Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era","volume":"117","author":"Wiestner","year":"2011","journal-title":"Blood"},{"key":"3","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/sj.leu.2402272","article-title":"Blastic variant of mantle cell lymphoma: a rare but highly aggressive subtype","volume":"15","author":"Ghandour","year":"2001","journal-title":"Leukemia"},{"key":"4","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/leu.2012.219","article-title":"Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cells","volume":"27","author":"Kung","year":"2013","journal-title":"Leukemia"},{"key":"5","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/cas.12430","article-title":"Induction of p53-mediated transcription and apoptosis by exportin-1 (XPO1) inhibition in mantle cell lymphoma","volume":"105","author":"Kimura","year":"2014","journal-title":"Cancer Sci"},{"key":"6","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.1182\/blood-2012-08-447581","article-title":"Prognostic impact and targeting of CRM1 in acute myeloid leukemia","volume":"121","author":"Kantarjian","year":"2013","journal-title":"Blood"},{"key":"7","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1182\/blood-2012-04-423160","article-title":"Preclinical activity of a novel CRM1 inhibitor in acute myeloid leukemia","volume":"120","author":"Garzon","year":"2012","journal-title":"Blood"},{"key":"8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.exphem.2012.09.002","article-title":"Novel selective inhibitors of nuclear export CRM1 antagonists for therapy in mantle cell lymphoma","volume":"41","author":"Pham","year":"2013","journal-title":"Experimental hematology"},{"key":"9","doi-asserted-by":"crossref","first-page":"e0137210","DOI":"10.1371\/journal.pone.0137210","article-title":"Ribosomal Biogenesis and Translational Flux Inhibition by the Selective Inhibitor of Nuclear Export (SINE) XPO1 Antagonist KPT-185","volume":"10","author":"Fujimura","year":"2015","journal-title":"PLoS One"},{"key":"10","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ccr.2006.04.023","article-title":"Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance","volume":"9","author":"Leder","year":"2006","journal-title":"Cancer Cell"},{"key":"11","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","article-title":"Metabolic reprogramming: a cancer hallmark even warburg did not anticipate","volume":"21","author":"Thompson","year":"2012","journal-title":"Cancer Cell"},{"key":"12","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Thompson","year":"2009","journal-title":"Science"},{"key":"13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000353164","article-title":"Class IA PI3K inhibition inhibits cell growth and proliferation in mantle cell lymphoma","volume":"131","author":"Miida","year":"2014","journal-title":"Acta Haematol"},{"key":"14","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrm2672","article-title":"Molecular mechanisms of mTOR-mediated translational control","volume":"10","author":"Blenis","year":"2009","journal-title":"Nat Rev Mol Cell Biol"},{"key":"15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/bjh.13065","article-title":"Targeting PI3-kinase (PI3K), AKT and mTOR axis in lymphoma","volume":"167","author":"Baiocchi","year":"2014","journal-title":"Br J Haematol"},{"key":"16","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Sabatini","year":"2012","journal-title":"Cell"},{"key":"17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrm3757","article-title":"Making new contacts: the mTOR network in metabolism and signalling crosstalk","volume":"15","author":"Hall","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"18","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/bjh.12945","article-title":"Time now to TORC the TORC? New developments in mTOR pathway inhibition in lymphoid malignancies","volume":"166","author":"Cwynarski","year":"2014","journal-title":"Br J Haematol"},{"key":"19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1042\/BJ20080281","article-title":"The TSC1-TSC2 complex: a molecular switchboard controlling cell growth","volume":"412","author":"Manning","year":"2008","journal-title":"Biochem J"},{"key":"20","doi-asserted-by":"publisher","first-page":"37930","DOI":"10.18632\/oncotarget.6122","article-title":"The novel combination of dual mTOR inhibitor AZD2014 and pan-PIM inhibitor AZD1208 inhibits growth in acute myeloid leukemia via HSF pathway suppression","volume":"6","author":"Tabe","year":"2015","journal-title":"Oncotarget"},{"key":"21","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.eururo.2015.08.035","article-title":"A Randomised Phase 2 Study of AZD2014 Versus Everolimus in Patients with VEGF-Refractory Metastatic Clear Cell Renal Cancer","volume":"69","author":"Hussain","year":"2016","journal-title":"Eur Urol"},{"key":"22","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1158\/1078-0432.CCR-14-2422","article-title":"First-in-Human Pharmacokinetic and Pharmacodynamic Study of the Dual m-TORC 1\/2 Inhibitor AZD2014","volume":"21","author":"de Bono","year":"2015","journal-title":"Clin Cancer Res"},{"key":"23","doi-asserted-by":"crossref","first-page":"33966","DOI":"10.1074\/jbc.M113.492702","article-title":"Rapamycin induces mitogen-activated protein (MAP) kinase phosphatase-1 (MKP-1) expression through activation of protein kinase B and mitogen-activated protein kinase kinase pathways","volume":"288","author":"Samavati","year":"2013","journal-title":"J Biol Chem"},{"key":"24","doi-asserted-by":"crossref","first-page":"8023","DOI":"10.1074\/jbc.M900301200","article-title":"An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1","volume":"284","author":"Gray","year":"2009","journal-title":"J Biol Chem"},{"key":"25","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1038\/leu.2011.339","article-title":"The dual mTORC1 and mTORC2 inhibitor AZD8055 has anti-tumor activity in acute myeloid leukemia","volume":"26","author":"Moura","year":"2012","journal-title":"Leukemia"},{"key":"26","doi-asserted-by":"publisher","first-page":"55083","DOI":"10.18632\/oncotarget.10397","article-title":"MLN0128, a novel mTOR kinase inhibitor, disrupts survival signaling and triggers apoptosis in AML and AML stem\/ progenitor cells","volume":"7","author":"Kornblau","year":"2016","journal-title":"Oncotarget"},{"key":"27","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.bbamcr.2010.10.012","article-title":"The importin \u03b2 binding domain as a master regulator of nucleocytoplasmic transport","volume":"1813","author":"Cingolani","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"28","article-title":"Tight coordination of protein translation and HSF1 activation supports the anabolic malignant state","volume":"341","author":"Porco","year":"2013","journal-title":"Science"},{"key":"29","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nri1086","article-title":"NODs: intracellular proteins involved in inflammation and apoptosis","volume":"3","author":"Nu\u00f1ez","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"30","first-page":"444","article-title":"2-Deoxy-D-glucose enhances sensitivity of human histiocytic lymphoma U937 cells to apoptosis induced by tumor necrosis factor","volume":"55","author":"Darzynkiewicz","year":"1995","journal-title":"Cancer Res"},{"key":"31","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1038\/onc.2009.448","article-title":"Glycolysis inhibition sensitizes tumor cells to death receptors-induced apoptosis by AMP kinase activation leading to Mcl-1 block in translation","volume":"29","author":"Ricci","year":"2010","journal-title":"Oncogene"},{"key":"32","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.leukres.2005.08.026","article-title":"Z-138 cell line was derived from a patient with blastoid variant mantle cell lymphoma","volume":"30","author":"Rassidakis","year":"2006","journal-title":"Leuk Res"},{"key":"33","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/sj.leu.2402272","article-title":"Blastic variant of mantle cell lymphoma: a rare but highly aggressive subtype","volume":"15","author":"Ghandour","year":"2001","journal-title":"Leukemia"},{"key":"34","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.leukres.2005.08.016","article-title":"Four human t(11;14)(q13;q32)-containing cell lines having classic and variant features of Mantle Cell Lymphoma","volume":"30","author":"Williams","year":"2006","journal-title":"Leuk Res"},{"key":"35","doi-asserted-by":"crossref","first-page":"424","DOI":"10.5858\/2003-127-0424-COMCLC","article-title":"Characterization of 4 mantle cell lymphoma cell lines","volume":"127","author":"Lai","year":"2003","journal-title":"Arch Pathol Lab Med"},{"key":"36","doi-asserted-by":"crossref","first-page":"4918","DOI":"10.1158\/0008-5472.CAN-08-4806","article-title":"Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry","volume":"69","author":"Soga","year":"2009","journal-title":"Cancer Res"},{"key":"37","first-page":"3","article-title":"The metabolic environment of cancer","volume":"81","author":"Azc\u00f3n-Bieto","year":"1988","journal-title":"Mol Cell Biochem"},{"key":"38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ccr.2007.05.008","article-title":"Defining the role of mTOR in cancer","volume":"12","author":"Sabatini","year":"2007","journal-title":"Cancer Cell"},{"key":"39","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1046\/j.1365-2141.1998.00911.x","article-title":"Establishment and characterization of a mantle cell lymphoma cell line","volume":"102","author":"Akagi","year":"1998","journal-title":"Br J Haematol"},{"key":"40","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0145-2126(97)00191-4","article-title":"Z-138: a new mature B-cell acute lymphoblastic leukemia cell line from a patient with transformed chronic lymphocytic leukemia","volume":"22","author":"Kurzrock","year":"1998","journal-title":"Leuk Res"},{"key":"41","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/ijc.2910380413","article-title":"Two new cell lines from B-prolymphocytic leukaemia: characterization by morphology, immunological markers, karyotype and Ig gene rearrangement","volume":"38","author":"Catovsky","year":"1986","journal-title":"Int J Cancer"},{"key":"42","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0145-2126(02)00013-9","article-title":"Establishment and characterization of a new mantle cell lymphoma cell line","volume":"26","author":"Ford","year":"2002","journal-title":"Mino. Leuk Res"},{"key":"43","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nmeth.2847","article-title":"Identification of small molecules that support human leukemia stem cell activity ex vivo","volume":"11","author":"Sauvageau","year":"2014","journal-title":"Nat Methods"},{"key":"44","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1126\/science.1191536","article-title":"Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells","volume":"329","author":"Cooke","year":"2010","journal-title":"Science"},{"key":"45","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1172\/JCI12807","article-title":"Therapeutic targeting of the MEK\/MAPK signal transduction module in acute myeloid leukemia","volume":"108","author":"Andreeff","year":"2001","journal-title":"J Clin Invest"},{"key":"46","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1021\/pr070378x","article-title":"iTRAQ-facilitated proteomic analysis of human prostate cancer cells identifies proteins associated with progression","volume":"7","author":"Rehman","year":"2008","journal-title":"J Proteome Res"},{"key":"47","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1021\/pr300624g","article-title":"Statistical inference from multiple iTRAQ experiments without using common reference standards","volume":"12","author":"Ruczinski","year":"2013","journal-title":"J Proteome Res"},{"key":"48","doi-asserted-by":"crossref","first-page":"5959","DOI":"10.1021\/pr300692t","article-title":"HILIC- and SCX-based quantitative proteomics of Chlamydomonas reinhardtii during nitrogen starvation induced lipid and carbohydrate accumulation","volume":"11","author":"Vaidyanathan","year":"2012","journal-title":"J Proteome Res"},{"key":"49","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1080\/00498250600861660","article-title":"Algorithms for network analysis in systems-ADME\/Tox using the MetaCore and MetaDrug platforms","volume":"36","author":"Nikolskaya","year":"2006","journal-title":"Xenobiotica"},{"key":"50","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","article-title":"Causal analysis approaches in Ingenuity Pathway Analysis","volume":"30","author":"Tugendreich","year":"2014","journal-title":"Bioinformatics"},{"key":"51","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1021\/pr034020m","article-title":"Quantitative metabolome analysis using capillary electrophoresis mass spectrometry","volume":"2","author":"Nishioka","year":"2003","journal-title":"J Proteome Res"},{"key":"52","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s11306-012-0452-2","article-title":"Metabolomic profiling of lung and prostate tumor tissues by capillary electrophoresis time-of-flight mass spectrometry","volume":"9","author":"Tomita","year":"2013","journal-title":"Metabolomics"},{"key":"53","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1269\/jrr.09011","article-title":"Microarray analysis of differentially expressed genes in the kidneys and testes of mice after long-term irradiation with low-dose-rate gamma-rays","volume":"50","author":"Magae","year":"2009","journal-title":"J Radiat Res"},{"key":"54","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.16602","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T22:59:56Z","timestamp":1658876396000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.16602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,27]]},"references-count":54,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2017,5,23]]}},"alternative-id":["16602","28388555"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.16602","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,27]]}}}